Ireland
Marama Labs, founded in 2017, is revolutionizing the field of UV-Vis analysis with its innovative CloudSpec instrument. Positioned under the slogan, "Nanoparticle Analysis Made Simple," the company provides a unique solution for analyzing cloudy liquids, a longstanding challenge in UV-Vis spectroscopy.
The proprietary technology, scatter-corrected absorption (SCA) spectroscopy, enables fast and accurate quantitative analysis of nanomedicines. This is highly relevant in industries requiring precision, such as drug development and manufacturing for vaccines, oncological treatments, and gene therapies. The technology promises significant time and cost efficiencies, crucial for product advancement and quality control.
Headquartered in Ireland, Marama Labs most recently secured a €1.75M Seed Round investment on 22 January 2024. Investors include Icehouse Ventures, NZ Growth Capital Partners, The Yield Lab Europe, Quidnet Ventures, Radar Ventures, NZVC, and DeepIE Ventures Management Co.
